149 related articles for article (PubMed ID: 17116296)
21. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
22. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.
Su H; Messer R; Whitmire W; Fischer E; Portis JC; Caldwell HD
J Exp Med; 1998 Sep; 188(5):809-18. PubMed ID: 9730883
[TBL] [Abstract][Full Text] [Related]
23. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.
Olsen AW; Theisen M; Christensen D; Follmann F; Andersen P
PLoS One; 2010 May; 5(5):e10768. PubMed ID: 20505822
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.
Shaw J; Grund V; Durling L; Crane D; Caldwell HD
Infect Immun; 2002 Mar; 70(3):1097-105. PubMed ID: 11854188
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of protective and immune responses following vaccination with recombinant MIP and CPAF from Chlamydia abortus as novel vaccines for enzootic abortion of ewes.
O'Neill LM; Keane OM; Ross PJ; Nally JE; Seshu J; Markey B
Vaccine; 2019 Aug; 37(36):5428-5438. PubMed ID: 31375438
[TBL] [Abstract][Full Text] [Related]
26. Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs.
Wali S; Gupta R; Veselenak RL; Li Y; Yu JJ; Murthy AK; Cap AP; Guentzel MN; Chambers JP; Zhong G; Rank RG; Pyles RB; Arulanandam BP
PLoS One; 2014; 9(12):e114261. PubMed ID: 25502875
[TBL] [Abstract][Full Text] [Related]
27. CD4+ T cells reduce the tissue burden of Chlamydia muridarum in male BALB/c mice.
Cunningham KA; Carey AJ; Timms P; Beagley KW
Vaccine; 2010 Jul; 28(31):4861-3. PubMed ID: 20653101
[TBL] [Abstract][Full Text] [Related]
28. Protection promoted by pGP3 or pGP4 against Chlamydia muridarum is mediated by CD4(+) cells in C57BL/6N mice.
Mosolygó T; Szabó AM; Balogh EP; Faludi I; Virók DP; Endrész V; Samu A; Krenács T; Burián K
Vaccine; 2014 Sep; 32(40):5228-33. PubMed ID: 25077421
[TBL] [Abstract][Full Text] [Related]
29. Oral Chlamydia vaccination induces transmucosal protection in the airway.
Zhu C; Lin H; Tang L; Chen J; Wu Y; Zhong G
Vaccine; 2018 Apr; 36(16):2061-2068. PubMed ID: 29550196
[TBL] [Abstract][Full Text] [Related]
30. A
Poston TB; Qu Y; Girardi J; O'Connell CM; Frazer LC; Russell AN; Wall M; Nagarajan UM; Darville T
J Immunol; 2017 Oct; 199(8):2845-2854. PubMed ID: 28855311
[No Abstract] [Full Text] [Related]
31. Chlamydial protease-like activity factor--insights into immunity and vaccine development.
Murthy AK; Guentzel MN; Zhong G; Arulanandam BP
J Reprod Immunol; 2009 Dec; 83(1-2):179-84. PubMed ID: 19853923
[TBL] [Abstract][Full Text] [Related]
32. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection.
Yang X; Gartner J; Zhu L; Wang S; Brunham RC
J Immunol; 1999 Jan; 162(2):1010-7. PubMed ID: 9916727
[TBL] [Abstract][Full Text] [Related]
33. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.
Su H; Caldwell HD
Infect Immun; 1995 Sep; 63(9):3302-8. PubMed ID: 7642259
[TBL] [Abstract][Full Text] [Related]
34. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.
Perry LL; Feilzer K; Caldwell HD
J Immunol; 1997 Apr; 158(7):3344-52. PubMed ID: 9120292
[TBL] [Abstract][Full Text] [Related]
35. Human antibody responses to a Chlamydia-secreted protease factor.
Sharma J; Bosnic AM; Piper JM; Zhong G
Infect Immun; 2004 Dec; 72(12):7164-71. PubMed ID: 15557641
[TBL] [Abstract][Full Text] [Related]
36. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
[TBL] [Abstract][Full Text] [Related]
37. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
[TBL] [Abstract][Full Text] [Related]
38. Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors.
Dong F; Sharma J; Xiao Y; Zhong Y; Zhong G
Infect Immun; 2004 Jul; 72(7):3869-75. PubMed ID: 15213129
[TBL] [Abstract][Full Text] [Related]
39. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
[TBL] [Abstract][Full Text] [Related]
40. In silico identification and in vivo analysis of a novel T-cell antigen from Chlamydia, NrdB.
Barker CJ; Beagley KW; Hafner LM; Timms P
Vaccine; 2008 Mar; 26(10):1285-96. PubMed ID: 18261829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
